2022-11-10T15:36:05-06:00 2021-12-31 390919055 RITZ HOLMAN LLP 330 E KILBOURN AVE SUITE 550 MILWAUKEE WI 53202 990 2021-01-01 237181863 SCOLIOSIS RESEARCH SOCIETY SCOL 4142899107 555 EAST WELLS STREET 1100 MILWAUKEE WI 53202 DAVID SKAGGS MD TREASURER 4142899107 2022-11-10 1 DAVID SKAGGS MD 999009999 KATY L SOMMER P00273273 4142711451 2022-11-10 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z CHRISTOPHER SHAFFREY MD 555 E WELLS STREET STE 1100 MILWAUKEE WI 53202 4902720 0 X WWW.SRS.ORG X 1966 IL THE PURPOSE OF THE SCOLIOSIS RESEARCH SOCIETY IS TO FOSTER THE OPTIMAL CARE OF ALL PATIENTS WITH SPINAL DEFORMITIES. 20 19 0 20 17000 13114 1267676 1821153 1169229 2252380 702511 587753 110692 28794 3250108 4690080 678213 337357 0 0 0 0 0 0 0 2065823 2884405 2744036 3221762 506072 1468318 17367746 19613993 401546 386628 16966200 19227365 X THE PURPOSE OF THE SCOLIOSIS RESEARCH SOCIETY IS TO FOSTER THE OPTIMAL CARE OF ALL PATIENTS WITH SPINAL DEFORMITIES. 0 0 219724 347550 IMAST (INTERNATIONAL MEETING ON ADVANCED SPINE TECHNIQUES) PROVIDES AN INTERNATIONAL SCIENTIFIC FORUM FOR SPINE PROFESSIONALS TO STAY UP-TO-DATE ON EMERGING NEW TECHNOLOGIES AND TECHNIQUES. SPINE SURGEONS AND OTHER ALLIED HEALTH PROFESSIONAL FROM AROUND THE WORLD DISCUSS, DEBATE, AND DEMONSTRATE RECENT ADVANCES IN SPINE SURGERY. 1001784 1425865 THE ANNUAL MEETING AND COURSE IS A FORUM FOR THE REALIZATION OF THE SOCIETY'S MISSION AND GOALS, THE IMPROVEMENT OF PATIENT CARE FOR THOSE WITH SPINAL DEFORMITIES. PRESENTATIONS AT THE ANNUAL MEETING & COURSE ARE GIVEN BY LEADING EXPERTS IN THE FIELD AND HAVE VALUE FOR HEALTH CARE PROFESSIONALS WHO TREAT SPINAL DEFORMITIES AT ALL LEVELS AND IN ALL AGES. OVER 100 PAPERS ARE PRESENTED ON AN ARRAY OF TOPICS, INCLUDING ADOLESCENT IDIOPATHIC SCOLIOSIS, GROWING SPINE, KYPHOSIS, ADULT DEFORMITY, TRAUMA, NEUROMUSCULAR SCOLIOSIS AND TUMORS. 311231 311231 425000 SRS COLLABORATES WITH CORPORATE PARTNERS AND THE INTERNATIONAL SPINE STUDY GROUP ON THE ASLS II STUDY. THIS STUDY IS A CONTINATION OF THE ASLS I STUDY WHICH WAS A PROSPECTIVE, RANDOMIZED NIH FUNDED STUDY THAT EVALUATED THE 2 YEAR TREATMENT OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR ADULT PATIENTS WITH SYMPTOMATIC LUMBAR SCOLIOSIS. ASLS II ALLOWS FOR LONGER TERM FOLLOW UP OF THE PATIENTS IN THE STUDY. 1033699 26126 206532 OTHER PROGRAM SERVICES: GLOBAL OUTREACH & WORLD WIDE COURSES; JOURNAL; TRAVELING FELLOWSHIP & SCHOLARSHIPS; RESEARCH; DIRECTED COURSES, SPINE DEFORMITY COURSES 1033699 26126 206532 2566438 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7 0 1 0 1 1 0 0 0 0 0 0 0 0 0 X 20 19 0 1 1 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 IL X EXECUTIVE DIRECTOR INC 4142766445 555 E WELLS ST STE 1100 MILWAUKEE WI 53202 X BENNY DAHL MD DIRECTOR 3.00 X 0 0 0 CHRISTOPHER I SHAFFREY MD PRESIDENT 7.00 X X 0 0 0 FERRAN PELLISE MD PHD SECRETARY 7.00 X X 0 0 0 GREGORY M MUNDIS JR MD DIRECTOR 3.00 X 0 0 0 HEE-KIT WONG MD DIRECTOR 3.00 X 0 0 0 JOHN T SMITH MD DIRECTOR 3.00 X 0 0 0 JUSTIN SMITH MD DIRECTOR 3.00 X 0 0 0 LAUREL C BLAKEMORE MD SECRETARY 7.00 X X 0 0 0 MARINUS DE KLEUVER MD PHD VICE PRESIDENT 3.00 X X 0 0 0 MUHARREM YAZICI MD PAST PRESIDENT 5.00 X X 0 0 0 PAUL D SPONSELLER MD MBA PAST PRESIDENT 5.00 X X 0 0 0 PETER O NEWTON MD PAST PRESIDENT 5.00 X X 0 0 0 RONALD A LEHMAN JR MD DIRECTOR 3.00 X 0 0 0 SERENA S HU MD PRESIDENT ELECT 5.00 X X 0 0 0 SUKEN A SHAH MD EDUCATION CHAIR 3.00 X 0 0 0 DAVID SKAGGS MD MMM TREASURER 7.00 X X 0 0 0 EVALINA BURGER MD DIRECTOR 3.00 X 0 0 0 MICHAEL KELLY MD DIRECTOR 3.00 X 0 0 0 KHALED KEBAISH MD DIRECTOR 3.00 X 0 0 0 DOUGLAS BURTON MD RESEARCH CHAIR 3.00 X 0 0 0 0 0 0 0 0 0 0 EXECUTIVE DIRECTOR INC 555 E WELLS STREET STE 1100 MILWAUKEE WI 53202 MANAGEMENT 1178284 1 1821153 1821153 ANNUAL MTNGS & WORKSHO 541900 1031000 1031000 MEMBERSHIP DUES & ASSE 541900 518482 518482 ASLS STUDY 541900 425000 425000 EXHIBIT FEE INCOME 541900 160000 160000 JOURNAL 541900 95098 95098 22800 22800 2252380 446980 446980 353413 212640 140773 140773 140773 3213 0 3213 3213 ADVERTISING 541800 17000 17000 OTHER REVENUE 541900 8581 8581 25581 4690080 2404947 17000 446980 214914 214914 122443 122443 1178284 767282 411002 8222 8222 12000 12000 92711 92711 321273 321273 4613 1258 3355 116860 80292 36568 128671 104077 24594 69613 61171 8442 736709 733460 3249 23676 23676 18526 8082 10444 STIPENDS 122629 82629 40000 ABSTRACT ARCHIVING 14471 14471 PRODUCTS AND PUBLICATIO 11740 11740 OTHER EXPENSES 11719 10982 737 12688 8688 4000 3221762 2566438 655324 0 1597001 2643131 506307 506999 754446 639893 72797 72797 533999 553057 13073487 14373827 111473 87797 718236 736492 17367746 19613993 210156 271178 191390 115450 401546 386628 X 15899706 16112954 1066494 3114411 16966200 19227365 17367746 19613993 1468318 792847 0 X 0 1 X 1 0 X 1939751 2500368 2495620 1761706 2339635 11037080 1939751 2500368 2495620 1761706 2339635 11037080 103397 10933683 137442 245443 256432 262971 446980 1349268 225000 265000 259500 80500 17000 847000 2442780 2641533 2628298 704209 1742479 10159299 23392647 6319 0.46740 0.42990 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER REVENUE - 2017 AMOUNT: $ 20,811. 2018 AMOUNT: $ 25,792. 2019 AMOUNT: $ 9,664. 2020 AMOUNT: $ 29,010. 2021 AMOUNT: $ 8,581. GROSS RECEIPTS FROM RELATED ACTIVITIES - 2017 AMOUNT: $ 2,421,969. 2018 AMOUNT: $ 2,615,741. 2019 AMOUNT: $ 2,618,634. 2020 AMOUNT: $ 675,199. 2021 AMOUNT: $ 1,733,898. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 0 X 5390216 792847 792847 4597369 92711 92711 4690080 3129051 0 3129051 92711 92711 3221762 PART V, LINE 4: RELYING ON PROFITS FROM MEETINGS AND DONATIONS FROM MEMBERS AND MEDICAL COMPANIES EACH YEAR, THE SRS BEGAN LIMITED RESEARCH FUNDING IN 1980. IN THE LATE 1980'S, SRS LEADERS DECIDED TO ESTABLISH A RESEARCH ENDOWMENT FUND IN ORDER TO GUARANTEE THE AVAILABLITY OF FUNDS FOR SCOLIOSIS RESEARCH. MOSTLY THROUGH DONATIONS FROM SRS MEMBERS, A GOAL OF $1.2 MILLION WAS REACHED IN 1992. INCOME FROM THIS FUND HAS BEEN USED EACH YEAR TO FUND PROJECTS SELECTED THROUGH A PEER-REVIEWED GRANT APPLICATION PROCESS. GRANT RECIPIENTS ARE REQUIRED TO PROVIDE REGULAR FINANCIAL REPORTS AND TO REPORT ON THE RESULTS OF THEIR RESEARCH AT AN SRS MEETING. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. HOWEVER, INCOME FROM CERTAIN ACTIVITIES (PRIMARILY ADVERTISING INCOME) NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. AS OF DECEMBER 31, 2021, THE ORGANIZATION HAD A TAX ASSET OF $5,257 FOR ESTIMATED PAYMENTS IN EXCESS OF ACTUAL UNRELATED BUSINESS INCOME TAX (UBIT). ESTIMATED TAX PAYMENTS AND PRIOR YEAR OVERPAYMENTS APPLIED TO 2021 TAX TOTALED $9,257. TOTAL UNRELATED BUSINESS INCOME TAX EXPENSE FOR THE YEAR ENDED DECEMBER 31, 2021, WAS $4,000. MANAGEMENT HAS REVIEWED ALL TAX POSITIONS RECOGNIZED IN PREVIOUSLY FILED TAX RETURNS IN THE U.S. FEDERAL AND STATE JURISDICTIONS AND THOSE EXPECTED TO BE TAKEN IN FUTURE TAX RETURNS. AS OF DECEMBER 31, 2021, THE ORGANIZATION HAD NO AMOUNTS RELATED TO UNRECOGNIZED INCOME TAX BENEFITS AND NO AMOUNTS RELATED TO ACCRUED INTEREST AND PENALTIES. THE ORGANIZATION DOES NOT ANTICIPATE ANY SIGNIFICANT CHANGES TO UNRECOGNIZED INCOME TAX BENEFITS OVER THE NEXT YEAR. 0 EAST ASIA & THE PACIFIC GRANTS TO RECIPIENTS LOCATED IN REGION 26748 EUROPE GRANTS TO RECIPIENTS LOCATED IN REGION SPINE DEFORMITY SOLUTIONS COURSE 52310 NORTH AMERICA GRANTS TO RECIPIENTS LOCATED IN REGION 39620 EUROPE GRANTS TO RECIPIENTS LOCATED IN REGION 56075 0 0 0 0 0 0 174753 0 174753 EAST ASIA & THE PACIFIC RESEARCH 19998 WIRE 0 FMV EUROPE RESEARCH 10000 WIRE 0 FMV NORTH AMERICA RESEARCH 9620 WIRE 0 FMV NORTH AMERICA RESEARCH 10000 WIRE 0 FMV EUROPE RESEARCH 29075 WIRE 0 FMV EUROPE RESEARCH 12000 WIRE 0 FMV EAST ASIA & THE PACIFIC RESEARCH 6750 WIRE 0 FMV NORTH AMERICA RESEARCH 20000 WIRE 0 FMV 9 0 0 0 0 0 0 PART I, LINE 2: WRITTEN APPLICATIONS SUBMITTED ARE REVIEWED BY THE RESEARCH GRANT OR AWARDS COMMITTEE. THOSE WHO RECEIVE RESEARCH GRANTS MUST ACKNOWLEDGE THAT THEY WILL SUBMIT WRITTEN PROGRESS AND FINANCIAL REPORTS AND THAT "IF FOR ANY REASON THE PROJECT FOR WHICH THE FUNDS WERE ALLOCATED CANNOT BE UNDERTAKEN WITHIN 12 MONTHS A FULL REFUND OF THE GRANT MONEY WILL BE MADE TO THE SRS," PRIOR TO DISTRIBUTION OF ANY FUNDS. SRS HAS A SPECIFIC GRANT REPORT FORM THAT IS TO BE COMPLETED AND COPIES OF THE GRANT REPORTS ARE KEPT IN SRS FILES. PART III ACCOUNTING METHOD: 1 THE CHILDREN'S HOSPITAL OF PHILADELPHIA 3615 CIVIC CENTER BLVD PHILADELPHIA PA 19104 231352166 501(C)(3) 50000 0 FMV RESEARCH GRANT STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 941444253 941156365 501(C)(3) 32000 0 FMV RESEARCH GRANT UNIVERSITY OF COLORADO DENVER 1800 N GRANT ST STE 600 DENVER CO 80203 846000555 501(C)(3) 20000 0 FMV RESEARCH GRANT REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILLMAN DRIVE LA JOLLA CA 92093 956006144 501(C)(3) 17396 0 FMV RESEARCH GRANT AMERICAN ACADEMY OF ORTHOPAEDIC SURGRONS 9400 W HIGGINS RD ROSEMONT IL 60018 362110592 501(C)(3) 15000 0 FMV BOARD OF SPECIALTY SOCIETIES SUPPORT TEXAS SOUTHERN RITE HOSPITAL 2222 WELBORN STREET DALLAS TX 75219 780818178 501(C)(3) 14378 0 FMV RESEARCH GRANT REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 220 MONTGOMERNY ST FL 5 SAN FRANCISCO CA 94104 946036493 501(C)(3) 12000 0 FMV RESEARCH GRANT THE CHILDREN'S HOSPITAL CORPORATION 300 LONGWOOD AVENUE BOSTON MA 021155724 042774441 501(C)(3) 11838 0 FMV RESEARCH GRANT BACK TO HEALING 3641 ERDLY LN SNELLVILLE GA 30039 812827904 501(C)(3) 10000 0 FMV SUPPORT KANSAS UNIVERSITY ENDOWMENT 1891 CONSTANT AVE LAWRENCE KS 66047 480547734 501(C)(3) 7500 0 FMV HISTORICAL MATERIALS FUND DONATION WASHINGTON UNIVERSITY 660 S EUCLID AVE ST LOUIS MO 63110 430653611 501(C)(3) 7500 0 FMV RESEARCH GRANT HOSPITAL FOR SPECIAL SURGERY 535 E 70TH ST NEW YORK NY 10021 131624135 501(C)(3) 7182 0 FMV RESEARCH GRANT PART I, LINE 2: WRITTEN APPLICATIONS SUBMITTED ARE REVIEWED BY THE RESEARCH GRANT OR AWARDS COMMITTEE. THOSE WHO RECEIVE RESEARCH GRANTS MUST ACKNOWLEDGE THAT THEY WILL SUBMIT WRITTEN PROGRESS AND FINANCIAL REPORTS AND THAT "IF FOR ANY REASON THE PROJECT FOR WHICH THE FUNDS WERE ALLOCATED CANNOT BE UNDERTAKEN WITHIN 12 MONTHS A FULL REFUND OF THE GRANT MONEY WILL BE MADE TO THE SRS," PRIOR TO DISTRIBUTION OF ANY FUNDS. SRS HAS A SPECIFIC GRANT REPORT FORM THAT IS TO BE COMPLETED AND COPIES OF THE GRANT REPORTS ARE KEPT IN SRS FILES. FORM 990, PART VI, SECTION A, LINE 3 LINE 3 EXPLANATION - SRS IS CONTRACTED WITH EXECUTIVE DIRECTOR, INC. (EDI) TO PROVIDE ASSOCIATION MANAGEMENT SERVICES. FORM 990, PART VI, SECTION A, LINE 4 CHANGES MADE TO THE BYLAWS INCLUDED ADDING AN ADDITIONAL COUNCIL AND COUNCIL CHAIR FOR COMMUNICATION ACTIVITIES AND VARIOUS CHANGES TO SECTION 7.10 VACANCIES. FORM 990, PART VI, SECTION A, LINE 6 LINE 6 EXPLANATION - SRS HAS SIX CLASSES OF MEMBERSHIP (REFERRED TO AS "FELLOWSHIP") NAMELY, CANDIDATE, ACTIVE, INACTIVE, ASSOCIATE, EMERITUS, AND HONORARY. FORM 990, PART VI, SECTION A, LINE 7A LINE 7A EXPLANATION - THE NOMINATING COMMITTEE PRESENTS A FINAL SLATE OF CANDIDATES TO THE SRS MEMBERSHIP AND THE CANDIDATES ARE ELECTED UPON RECEIVING A MAJORITY OF THE VOTES CAST BY ACTIVE FELLOWS AT THE ANNUAL MEETING. FORM 990, PART VI, SECTION A, LINE 7B LINE 7B EXPLANATION - THERE ARE THREE DECISIONS THAT REQUIRE A VOTE BY THE MEMBERS: ELECTION OF OFFICERS, REMOVAL OF AN OFFICER AND AMENDMENTS TO THE BYLAWS. ONLY ACTIVE MEMBERS IN GOOD STANDING MAY VOTE, AND THEY MUST VOTE IN PERSON AT THE ANNUAL MEETING OR AT A SPECIAL MEETING, IF ONE IS CALLED. ELECTION OF OFFICERS REQUIRES ONLY A SIMPLE MAJORITY. AMENDMENTS AND REMOVAL OF AN OFFICER REQURE A 2/3 MAJORITY OF THOSE PRESENT. FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE BOARD OF DIRECTORS RECEIVES AND REVIEWS A COPY OF THE FORM 990 AND ALL APPLICABLE SCHEDULES. AFTER THE BOARD APPROVES OF THE FORM, IT IS SIGNED BY A SELECTED OFFICER AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C MANAGEMENT REVIEWS THE DISCLOSURE FORMS AND INFORMS THE BOARD OF ANY POSSIBLE CONFLICTS. THE FORMS ARE KEPT ON FILE AND AVAILABLE FOR THE BOARD OF DIRECTORS TO REVIEW. FORM 990, PART VI, SECTION B, LINE 15 SRS IS MANAGED BY EXECUTIVE DIRECTOR, INC., A FOR-PROFIT MANAGEMENT COMPANY. SRS HAS NO OFFICIAL EMPLOYEES BECAUSE ALL STAFF ASSIGNED TO SRS ARE EMPLOYEES OF THE MANAGEMENT COMPANY. SRS CONTRACTS WITH EXECUTIVE DIRECTOR, INC TO PROVIDE OFFICE FACILITIES, MANAGEMENT, RECORD KEEPING, ACCOUNTING, STORAGE, OTHER SIGNIFICANT SERVICES AND RELATED OVERCOST. THE ASSOCIATION MANAGEMENT FEE IS REVIEWED AT LEAST ONCE A YEAR BY THE BOARD, USUALLY DURING THE BUDGETING PROCESS FOR THE NEXT YEAR. SRS DOES NOT HAVE ANYBODY WHO FITS THE DEFINITION OF A KEY EMPLOYEE. REASONABLE COMPENSATION FOR SERVICES RENDERED TO OR FOR SRS TO OFFICERS IS ANNUALLY REVIEWED AND APPROVED BY THE BOARD DURING THE BUDGETING PROCESS. FORM 990, PART VI, SECTION C, LINE 19 SRS MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FORM 990/990-T AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. ALL REQUESTS SHOULD BE MADE TO THE SRS OFFICE AND A PRINT OR ELECTRONIC COPY OF THE REQUESTED DOCUMENTS WILL BE PROVIDED.